Conatus Pharmaceuticals Reports 2013 Financial Results and Program Updates

Published March 30, 2014

Conatus Pharmaceuticals Reports 2013 Financial Results and Program Updates
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to emricasan in late 2013 for the treatment of liver transplant recipients with reestablished fibrosis to delay the progression to cirrhosis and end-stage liver disease. In …
Read more on GlobeNewswire (press release)

AF Ablation vs Drugs: Lessons From the Rich Peverley Case
Hindsight is sharp, but the question in the Peverley case centers on the initial rhythm-control strategy for AF. … You know, things like weight loss, attention to blood pressure, treatment of sleep apnea, and avoidance of alcohol. … In the last …
Read more on Medscape

Dr. Harold Vann's Coping with Life Based on Experience-Created Wisdom
After his retirement, Dr. Vann began working with addicts in both jails and rehab centers. As a result of the … The path to coping with grief encompassed in the book's pathway is worth more than any monetary cost. The twelve stages of … One day …
Read more on Clarksville Online

Related Pathways Alcohol And Drug Treatment Center Information…